Literature DB >> 6749881

Characterization of somatomedin binding in human serum by ultracentrifugation and gel filtration.

W H Daughaday, A P Ward, A C Goldberg, B Trivedi, M Kapadia.   

Abstract

It is known that the somatomedins exist in human serum complexed to specific binding proteins. The existence of unbound somatomedins in serum has never unequivocally been demonstrated. We have characterized the distribution of insulin-like growth factor (IGF) I in different fractions after gel filtration of serum through Sephadex G-200 in neutral buffer. IGF-I was measured by RIA after acid extraction. Seventy-two percent of serum IGF-I was associated with large complexes with an estimated size of about 150,000 daltons and 25% was associated with smaller complexes of about 50,000 daltons. No unbound IGF-I was detected. Ultracentrifugation of 10 ml fresh serum was carried out at 106,000 X g for 17 h, after which the tube was aspirated in 1-ml fractions beginning at the top. IGF-I by RIA in fractions 2 and 3 sedimented with albumin; in fractions 4 to 7, the sedimentation pattern approached that of immunoglobulin G. This shift is consistent with the size distribution of IGF-I complexes demonstrated by gel filtration. The failure to find any significant increase in the concentration of IGF-I relative to albumin in the top 30% of the tube (fractions 1-3) after centrifugation argues against the presence of measurable free IGF-I in these fractions. The ability of upper fractions to bind added [125I]IGF-II proved to closely approximate the binding of the initial serum, indicating little sedimentation of the accessible binding protein. The relative binding of [125I]IGF-II by serum aliquots proved to be markedly concentration dependent. At concentrations above 5% serum, the incremental increase of binding as a function of serum concentration was much reduced. We interpret this to indicate that with dilution there is a dissociation of complexes and an increase in accessible binding sites. This phenomenon may modify tissue delivery of somatomedins in interstitial fluid. The data suggest that in undiluted serum there is no significant concentration of free somatomedins but at the dilution of serum that exists in the interstitial fluid, dissociation of bound somatomedins may be facilitated.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6749881     DOI: 10.1210/jcem-55-5-916

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

1.  Criteria for the cure of acromegaly: comparison between basal growth hormone and somatomedin C plasma concentrations in active and non-active acromegalic patients.

Authors:  D Giannella-Neto; B L Wajchenberg; B B Mendonça; S F Almeida; M Macchione; E M Spencer
Journal:  J Endocrinol Invest       Date:  1988-01       Impact factor: 4.256

2.  Effects of growth hormone and insulin-like growth factor I on rabbit proximal convoluted tubule transport.

Authors:  R Quigley; M Baum
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

3.  Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling.

Authors:  R C Baxter; J L Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

4.  Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: a potential local regulator of IGF action.

Authors:  S Mohan; C M Bautista; J Wergedal; D J Baylink
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

5.  Activity in fetal bovine serum that stimulates erythroid colony formation in fetal mouse livers is insulinlike growth factor I.

Authors:  A Kurtz; W Härtl; W Jelkmann; J Zapf; C Bauer
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

6.  Affinity-labeled plasma somatomedin-C/insulinlike growth factor I binding proteins. Evidence of growth hormone dependence and subunit structure.

Authors:  J R Wilkins; A J D'Ercole
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

7.  Abnormal serum IGF-II transport in non-islet cell tumor hypoglycemia results from abnormalities of both IGF binding protein-3 and acid labile subunit and leads to elevation of serum free IGF-II.

Authors:  W H Daughaday; B Trivedi; R C Baxter
Journal:  Endocrine       Date:  1995-06       Impact factor: 3.633

8.  Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II.

Authors:  E T Shapiro; G I Bell; K S Polonsky; A H Rubenstein; M C Kew; H S Tager
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

9.  The effects of infusion of insulinlike growth factor (IGF) I, IGF-II, and insulin on glucose and protein metabolism in fasted lambs.

Authors:  R G Douglas; P D Gluckman; K Ball; B Breier; J H Shaw
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

10.  Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.

Authors:  S R Kupfer; L E Underwood; R C Baxter; D R Clemmons
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.